Cochlear Americas has announced it has received FDA approval for its Nucleus CI422 with slim straight electrode, according to a news release.
It is the newest electrode in Cochlear's portfolio of implantable hearing solutions
"This approval underscores Cochlear's design philosophy, which is to take the very best of what we've learned from each generation of electrode and apply it to improve the next," said Chris Smith, president of Cochlear Americas, in the release. "The addition of the Nucleus CI422, the world's thinnest, full length electrode, to our comprehensive portfolio is a strong testament to our ongoing collaboration with surgeons and clinicians to help meet the individual needs of patients."
Cochlear Americas is headquartered in Centennial, Colo.
Related Articles on FDA Approvals:
Mevion Medical Systems Receives FDA 510(k) Clearance for Proton Therapy System
Hansen Medical Receives FDA 510(k) Clearance for Peripheral Vascular Interventions System
Medicrea Receives FDA Clearance for the LigaPASS Spinal Fixation System